From: Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer’s disease
Dose
Day
Cmax, µg/mL
Clearance, mL/h/kg
AUC0 − 168, h●µg/mL
20 mg/kga
1
401
NA
25,800
22
504
0.615
33,700
80 mg/kga
1590
82,100
1560
0.811
99,400
250 mg/kgb
4430
219,000
5130
0.976
265,000